Hypoxia in human colorectal adenocarcinoma: Comparison between extrinsic and potential intrinsic hypoxia markers

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 1, 2006, Pages 246-254

  Goethals, Laurence ^a   Debucquoy, Annelies ^a   Perneel, Christiaan ^b   Geboes, Karel ^a   Ectors, Nadine ^a   De Schutter, Harlinde ^a   Penninckx, Freddy ^a   McBride, William H ^c   Begg, Adrian C ^d   Haustermans, Karin M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ROYAL MILITARY ACADEMY   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Colorectal tumors; Endogenous markers; Hypoxia; IdUrd; Pimonidazole

Indexed keywords

BIOMARKERS; BIOPSY; CELLS; SURGERY; TUMORS;

COLORECTAL TUMORS; ENDOGENOUS MARKERS; HYPOXIA; IDURD; PIMONIDAZOLE;

DISEASES;

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR; IDOXURIDINE; KI 67 ANTIGEN; PIMONIDAZOLE; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STAINING; TUMOR BIOPSY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARBONIC ANHYDRASES; CELL HYPOXIA; COLONIC NEOPLASMS; FEMALE; HUMANS; IDOXURIDINE; MALE; MICROCIRCULATION; MIDDLE AGED; NITROIMIDAZOLES; OBSERVER VARIATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECTAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646003243     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.007     Document Type: Article

References (46)

1. Brizel D.M., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
2. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 (1996) 4509-4515
3. Nordsmark M., Overgaard M., and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41 (1996) 31-39
4. Brown J.M. The hypoxic cell. A target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59 (1999) 5863-5870
5. Brown J.M. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52 (1979) 650-656
6. Thomlinson R.H., and Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9 (1955) 539-549
7. van Laarhoven H.W., Kaanders J.H., Lok J., et al. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer. Int J Radiat Oncol Biol Phys 64 (2006) 473-482
8. Bussink J., Kaanders J.H., and van der Kogel A.J. Tumor hypoxia at the micro-regional level. Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67 (2003) 3-15
9. Ljungkvist A.S., Bussink J., Rijken P.F., et al. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 54 (2002) 215-228
10. Rijken P.F., Bernsen H.J., Peters J.P., et al. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft. A quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 48 (2000) 571-582
11. Raleigh J.A., Chou S.C., Arteel G.E., et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151 (1999) 580-589
12. Ivanov S., Liao S.Y., Ivanova A., et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158 (2001) 905-919
13. Wykoff C.C., Beasley N.J., Watson P.H., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 (2000) 7075-7083
14. Saarnio J., Parkkila S., Parkkila A.K., et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153 (1998) 279-285
15. Laderoute K.R., Grant T.D., Murphy B.J., et al. Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. Int J Cancer 52 (1992) 428-432
16. Grandis J.R., Melhem M.F., Gooding W.E., et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90 (1998) 824-832
17. Moscatello D.K., Holgado-Madruga M., Godwin A.K., et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 55 (1995) 5536-5539
18. Forsythe J.A., Jiang B.H., Iyer N.V., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613
19. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
20. Dunst J., Stadler P., Becker A., et al. Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers. Strahlenther Onkol 177 (2001) 469-473
21. Lal A., Peters H., St Croix B., et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93 (2001) 1337-1343
22. Begg A.C., Hofland I., Van DP I., et al. Use of thymidine analogues to indicate vascular perfusion in tumours. Br J Cancer 83 (2000) 899-905
23. Begg A.C., Janssen H.L., Sprong D., et al. Hypoxia and perfusion measurements in human tumors. Initial experience with pimonidazole and IUdR. Acta Oncol 40 (2001) 924-928
24. Janssen H.L., Haustermans K.M., Sprong D., et al. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 54 (2002) 1537-1549
25. Janssen H.L., Ljungkvist A.S., Rijken P.F., et al. Thymidine analogues to assess microperfusion in human tumors. Int J Radiat Oncol Biol Phys 62 (2005) 1169-1175
26. Pastorekova S., Zavadova Z., Kostal M., et al. A novel quasi-viral agent, MaTu, is a two-component system. Virology 187 (1992) 620-626
27. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
28. Wijffels K.I., Kaanders J.H., Rijken P.F., et al. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br J Cancer 83 (2000) 674-683
29. Kennedy A.S., Raleigh J.A., Perez G.M., et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix. First report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys 37 (1997) 897-905
30. Olive P.L., Aquino-Parsons C., MacPhail S.H., et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61 (2001) 8924-8929
31. Airley R.E., Loncaster J., Raleigh J.A., et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix. Relationship to pimonidazole binding. Int J Cancer 104 (2003) 85-91
32. Hoskin P.J., Sibtain A., Daley F.M., et al. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiother Oncol 72 (2004) 159-168
33. Hoskin P.J., Sibtain A., Daley F.M., et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer. Relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 89 (2003) 1290-1297
34. Troost E.G., Bussink J., Kaanders J.H., et al. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. Radiother Oncol 76 (2005) 194-199
35. 2 tension. Am J Physiol 271 (1996) C1172-C1180
36. Varghese A.J., Gulyas S., and Mohindra J.K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res 36 (1976) 3761-3765
37. Kuwai T., Kitadai Y., Tanaka S., et al. Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma. Association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci 95 (2004) 149-153
38. Miyakis S., Sourvinos G., Liloglou T.L., et al. The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 88 (2000) 503-505
39. Zhuang Z., Emmert-Buck M.R., Roth M.J., et al. von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. Hum Pathol 27 (1996) 152-156
40. Kivela A.J., Parkkila S., Saarnio J., et al. Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa. World J Gastroenterol 11 (2005) 2616-2625
41. Kwon S.J., and Lee Y.J. Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin Cancer Res 11 (2005) 4694-4700
42. Vordermark D., Kaffer A., Riedl S., et al. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61 (2005) 1197-1207
43. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58 (1998) 3765-3768
44. Fukumura D., Xu L., Chen Y., et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61 (2001) 6020-6024
45. Bos R., van Diest P.J., de Jong J.S., et al. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46 (2005) 31-36
46. Hirami Y., Aoe M., Tsukuda K., et al. Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1alpha in non-small cell lung cancers. Cancer Lett 214 (2004) 157-164